Novavax Hopes COVID-19/Flu Vaccine Combo Can Help It Keep Up With mRNA Leaders

But COVID-19 Component Not Updated

Novavax
Novavax reached the market too late to make a big impression, but wants to stake a claim in the post-pandemic market with a combined covid and flu jab. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip